Denosumab-Bmwo Drug Interactions: 12 Major, 247 Moderate
Denosumab-Bmwo Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Denosumab-Bmwo. Always confirm against the full prescribing information.
100 interactions
Abatacept
The risk or severity of adverse effects can be increased when Denosumab is combined with Abatacept.
Level 1 evidence
Adalimumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Adalimumab.
Level 1 evidence
Aldesleukin
The risk or severity of adverse effects can be increased when Denosumab is combined with Aldesleukin.
Level 1 evidence
Alemtuzumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Alemtuzumab.
Level 1 evidence
Anakinra
The risk or severity of adverse effects can be increased when Denosumab is combined with Anakinra.
Level 1 evidence
Anifrolumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Anifrolumab.
Level 1 evidence
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Denosumab.
Level 2 evidence
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Denosumab is combined with Antilymphocyte immunoglobulin (horse).
Level 1 evidence
Antithymocyte immunoglobulin (rabbit)
The risk or severity of adverse effects can be increased when Denosumab is combined with Antithymocyte immunoglobulin (rabbit).
Level 1 evidence
Apremilast
The risk or severity of adverse effects can be increased when Denosumab is combined with Apremilast.
Level 1 evidence
Arsenic trioxide
The risk or severity of adverse effects can be increased when Denosumab is combined with Arsenic trioxide.
Level 1 evidence
AstraZeneca COVID-19 Vaccine
The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Denosumab.
Level 2 evidence
Enter your NPI to unlock 4 major interactions for Denosumab-Bmwo
Denosumab-Bmwo has 378 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Denosumab-Bmwo has 12 major, 247 moderate, and 119 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Denosumab-Bmwo. Always confirm against the full prescribing information.